0001209191-15-081520.txt : 20151120 0001209191-15-081520.hdr.sgml : 20151120 20151120160924 ACCESSION NUMBER: 0001209191-15-081520 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151118 FILED AS OF DATE: 20151120 DATE AS OF CHANGE: 20151120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCGLYNN MARGARET G CENTRAL INDEX KEY: 0001215126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 151246801 MAIL ADDRESS: STREET 1: C/O MERCK & CO INC STREET 2: ONE MERCK DRIVE PO BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-11-18 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001215126 MCGLYNN MARGARET G C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2015-11-18 4 M 0 12500 57.27 A 13588 D Common Stock 2015-11-18 4 S 0 12500 130.15 D 1088 D Stock Option (right to buy) 57.27 2015-11-18 4 M 0 12500 0.00 D 2021-05-11 Common Stock 12500 0 D Transaction made pursuant to Ms. McGlynn's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $130.15 (range $130.00 to $130.55). Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Fully vested. Omar White, Attorney-In-Fact 2015-11-20